{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:19:28Z","timestamp":1793827168716,"version":"4.6.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"DOI":"10.1038\/s41423-025-01356-w","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T07:48:52Z","timestamp":1760428132000},"page":"1581-1597","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["IL-18 drives the Bhlhe40-mediated pathogenic Th17 cell response and exacerbates autoimmune disease progression"],"prefix":"10.1038","volume":"22","author":[{"given":"Yuan","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingbo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingqin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4540-452X","authenticated-orcid":false,"given":"Fan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Qing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqian","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongzhou","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6878-5129","authenticated-orcid":false,"given":"Ke","family":"Rui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8634-0967","authenticated-orcid":false,"given":"Liwei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"key":"1356_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-024-01952-8","volume":"9","author":"Y Song","year":"2024","unstructured":"Song Y, Li J, Wu Y. Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders. Sig Transduct Target Ther. 2024;9:1\u201340.","journal-title":"Sig Transduct Target Ther"},{"key":"1356_CR2","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/s41584-019-0277-8","volume":"15","author":"CA Dinarello","year":"2019","unstructured":"Dinarello CA. The IL-1 family of cytokines and receptors in rheumatic diseases. Nat Rev Rheumatol. 2019;15:612\u201332.","journal-title":"Nat Rev Rheumatol"},{"key":"1356_CR3","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190314","volume":"217","author":"AH Chan","year":"2020","unstructured":"Chan AH, Schroder K. Inflammasome signaling and regulation of interleukin-1 family cytokines. Journal Exp Med. 2020;217:e20190314.","journal-title":"Journal Exp Med"},{"key":"1356_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/rai2.12155","volume":"4","author":"M Pan","year":"2024","unstructured":"Pan M, Yang J, Jiang Z. Inflammasomes and their roles in autoimmune diseases. Rheumatology Autoimmun. 2024;4:197\u2013217.","journal-title":"Rheumatology Autoimmun"},{"key":"1356_CR5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S1074-7613(00)80543-9","volume":"8","author":"K Takeda","year":"1998","unstructured":"Takeda K, Tsutsui H, Yoshimoto T, Adachi O, Yoshida N, Kishimoto T, et al. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity. 1998;8:383\u201390.","journal-title":"Immunity"},{"key":"1356_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2021.155781","volume":"150","author":"M Harel","year":"2022","unstructured":"Harel M, Fauteux-Daniel S, Girard-Guyonvarc\u2019h C, Gabay C. Balance between Interleukin-18 and Interleukin-18 binding protein in autoinflammatory diseases. Cytokine. 2022;150:155781.","journal-title":"Cytokine"},{"key":"1356_CR7","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3109\/14397595.2015.1021409","volume":"26","author":"Y Chen","year":"2016","unstructured":"Chen Y, Deng F, Zheng J, Yin J, Huang R, Liu W, et al. High circulating level of interleukin-18 in patients with primary Sj\u00f6gren\u2019s syndrome is associated with disease activity. Modern Rheumatol. 2016;26:156\u20138.","journal-title":"Modern Rheumatol"},{"key":"1356_CR8","doi-asserted-by":"publisher","first-page":"5338","DOI":"10.4049\/jimmunol.167.9.5338","volume":"167","author":"E Esfandiari","year":"2001","unstructured":"Esfandiari E, McInnes IB, Lindop G, Huang FP, Field M, Komai-Koma M, et al. A Proinflammatory Role of IL-18 in the Development of Spontaneous Autoimmune Disease1. J Immunol. 2001;167:5338\u201347.","journal-title":"J Immunol"},{"key":"1356_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-84170-4","volume":"11","author":"M Xiang","year":"2021","unstructured":"Xiang M, Feng Y, Wang Y, Wang J, Zhang Z, Liang J, et al. Correlation between circulating interleukin-18 level and systemic lupus erythematosus: a meta-analysis. Sci Rep. 2021;11:4707.","journal-title":"Sci Rep."},{"key":"1356_CR10","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/s41577-021-00596-x","volume":"21","author":"C Dong","year":"2021","unstructured":"Dong C. Defining the TH17 cell lineage. Nat Rev Immunol. 2021;21:618.","journal-title":"Nat Rev Immunol"},{"key":"1356_CR11","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/ni1261","volume":"6","author":"H Park","year":"2005","unstructured":"Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005;6:1133\u201341.","journal-title":"Nat Immunol"},{"key":"1356_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41590-022-01387-9","volume":"24","author":"A Schnell","year":"2023","unstructured":"Schnell A, Littman DR, Kuchroo VK. TH17 cell heterogeneity and its role in tissue inflammation. Nat Immunol. 2023;24:19\u201329.","journal-title":"Nat Immunol"},{"key":"1356_CR13","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1136\/annrheumdis-2013-204584","volume":"74","author":"X Lin","year":"2015","unstructured":"Lin X, Rui K, Deng J, Tian J, Wang X, Wang S, et al. Th17 cells play a critical role in the development of experimental Sj\u00f6gren\u2019s syndrome. Ann Rheum Dis. 2015;74:1302\u201310.","journal-title":"Ann Rheum Dis"},{"key":"1356_CR14","doi-asserted-by":"publisher","first-page":"R220","DOI":"10.1186\/ar3207","volume":"12","author":"CQ Nguyen","year":"2010","unstructured":"Nguyen CQ, Yin H, Lee BH, Carcamo WC, Chiorini JA, Peck AB. Pathogenic effect of interleukin-17A in induction of Sj\u00f6gren\u2019s syndrome-like disease using adenovirus-mediated gene transfer. Arthritis Res Ther. 2010;12:R220.","journal-title":"Arthritis Res Ther"},{"key":"1356_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1277","volume":"10","author":"F Xiao","year":"2021","unstructured":"Xiao F, Du W, Zhu X, Tang Y, Liu L, Huang E, et al. IL-17 drives salivary gland dysfunction by inhibiting TRPC1-mediated calcium movement in Sj\u00f6gren\u2019s syndrome. Clin Transl Immunol. 2021;10:e1277.","journal-title":"Clin Transl Immunol"},{"key":"1356_CR16","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1038\/s41423-020-00540-4","volume":"18","author":"K Ma","year":"2021","unstructured":"Ma K, Du W, Xiao F, Han M, Huang E, Peng N, et al. IL-17 sustains the plasma cell response via p38-mediated Bcl-xL RNA stability in lupus pathogenesis. Cell Mol Immunol. 2021;18:1739\u201350.","journal-title":"Cell Mol Immunol"},{"key":"1356_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/imm.13280","volume":"163","author":"S Cerboni","year":"2021","unstructured":"Cerboni S, Gehrmann U, Preite S, Mitra S. Cytokine-regulated Th17 plasticity in human health and diseases. Immunology. 2021;163:3\u201318.","journal-title":"Immunology"},{"key":"1356_CR18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.immuni.2015.11.009","volume":"44","author":"R Jain","year":"2016","unstructured":"Jain R, Chen Y, Kanno Y, Joyce-Shaikh B, Vahedi G, Hirahara K, et al. Interleukin-23-Induced Transcription Factor Blimp-1 Promotes Pathogenicity of T Helper 17 Cells. Immunity. 2016;44:131\u201342.","journal-title":"Immunity"},{"key":"1356_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154818","volume":"250","author":"M Toghi","year":"2023","unstructured":"Toghi M, Bitarafan S, Ghafouri-Fard S. Pathogenic Th17 cells in autoimmunity with regard to rheumatoid arthritis. Pathology - Res Pract. 2023;250:154818.","journal-title":"Pathology - Res Pract"},{"key":"1356_CR20","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nature09447","volume":"467","author":"K Ghoreschi","year":"2010","unstructured":"Ghoreschi K, Laurence A, Yang XP, Tato CM, McGeachy MJ, Konkel JE, et al. Generation of pathogenic T(H)17 cells in the absence of TGF-\u03b2 signaling. Nature. 2010;467:967\u201371.","journal-title":"Nature"},{"key":"1356_CR21","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/ni1539","volume":"8","author":"MJ McGeachy","year":"2007","unstructured":"McGeachy MJ, Bak-Jensen KS, Chen Y, Tato CM, Blumenschein W, McClanahan T, et al. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol. 2007;8:1390\u20137.","journal-title":"Nat Immunol"},{"key":"1356_CR22","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.cell.2015.11.009","volume":"163","author":"JT Gaublomme","year":"2015","unstructured":"Gaublomme JT, Yosef N, Lee Y, Gertner RS, Yang LV, Wu C, et al. Single-Cell Genomics Unveils Critical Regulators of Th17 Cell Pathogenicity. Cell. 2015;163:1400\u201312.","journal-title":"Cell"},{"key":"1356_CR23","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ni.2416","volume":"13","author":"Y Lee","year":"2012","unstructured":"Lee Y, Awasthi A, Yosef N, Quintana FJ, Xiao S, Peters A, et al. Induction and molecular signature of pathogenic TH17 cells. Nat Immunol. 2012;13:991\u20139.","journal-title":"Nat Immunol"},{"key":"1356_CR24","doi-asserted-by":"publisher","first-page":"52ra72","DOI":"10.1126\/scitranslmed.3001107","volume":"2","author":"W Hueber","year":"2010","unstructured":"Hueber W, Patel DD, Dryja T, Wright AM, Koroleva I, Bruin G, et al. Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis. Science Transl Med. 2010;2:52ra72.","journal-title":"Science Transl Med"},{"key":"1356_CR25","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1056\/NEJMoa1314258","volume":"371","author":"RG Langley","year":"2014","unstructured":"Langley RG, Elewski BE, Lebwohl M, Reich K, Griffiths CEM, Papp K, et al. Secukinumab in plaque psoriasis-results of two phase 3 trials. N Engl J Med. 2014;371:326\u201338.","journal-title":"N Engl J Med"},{"key":"1356_CR26","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1136\/gutjnl-2011-301668","volume":"61","author":"W Hueber","year":"2012","unstructured":"Hueber W, Sands BE, Lewitzky S, Vandemeulebroecke M, Reinisch W, Higgins PDR, et al. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn\u2019s disease: unexpected results of a randomized, double-blind placebo-controlled trial. Gut. 2012;61:1693\u2013700.","journal-title":"Gut"},{"key":"1356_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106187","volume":"80","author":"B Wu","year":"2020","unstructured":"Wu B, Wan Y. Molecular control of pathogenic Th17 cells in autoimmune diseases. Int Immunopharmacol. 2020;80:106187.","journal-title":"Int Immunopharmacol"},{"key":"1356_CR28","doi-asserted-by":"publisher","first-page":"4168","DOI":"10.1016\/j.cell.2021.05.045","volume":"184","author":"A Wagner","year":"2021","unstructured":"Wagner A, Wang C, Fessler J, DeTomaso D, Avila-Pacheco J, Kaminski J, et al. Metabolic modeling of single Th17 cells reveals regulators of autoimmunity. Cell. 2021;184:4168\u20134185.e21.","journal-title":"Cell"},{"key":"1356_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112205","volume":"42","author":"TY Huang","year":"2023","unstructured":"Huang TY, Hirota M, Sasaki D, Kalra RS, Chien HC, Tamai M, et al. Phosphoenolpyruvate regulates the Th17 transcriptional program and inhibits autoimmunity. Cell Rep. 2023;42:112205.","journal-title":"Cell Rep."},{"key":"1356_CR30","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1136\/annrheumdis-2018-213615","volume":"77","author":"K Ma","year":"2018","unstructured":"Ma K, Li J, Wang X, Lin X, Du W, Yang X, et al. TLR4+ CXCR4+ plasma cells drive nephritis development in systemic lupus erythematosus. Ann Rheum Dis. 2018;77:1498\u2013506.","journal-title":"Ann Rheum Dis"},{"key":"1356_CR31","doi-asserted-by":"crossref","unstructured":"Kuriki Y, Liu Y, Xia D, Gjerde EM, Khalili S, Mui B, et al. Cannulation of the mouse submandibular salivary gland via the Wharton\u2019s duct. J Vis Exp. 2011;51:3074.","DOI":"10.3791\/3074"},{"key":"1356_CR32","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1007\/s12026-022-09296-7","volume":"70","author":"R Fakhfakh","year":"2022","unstructured":"Fakhfakh R, Zian Z, Elloumi N, Abida O, Bouallegui E, Houssaini H, et al. Th17 and Th1 cells in systemic lupus erythematosus with focus on lupus nephritis. Immunol Res. 2022;70:644\u201353.","journal-title":"Immunol Res"},{"key":"1356_CR33","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jaut.2017.11.003","volume":"87","author":"GM Verstappen","year":"2018","unstructured":"Verstappen GM, Corneth OBJ, Bootsma H, Kroese FGM. Th17 cells in primary Sj\u00f6gren\u2019s syndrome: pathogenicity and plasticity. J Autoimmun. 2018;87:16\u201325.","journal-title":"J Autoimmun"},{"key":"1356_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0091-6749(99)70518-X","volume":"103","author":"CA Dinarello","year":"1999","unstructured":"Dinarello CA. IL-18: A TH1 -inducing, proinflammatory cytokine and new member of the IL-1 family. Journal Allergy Clin Immunol. 1999;103:11\u201324.","journal-title":"Journal Allergy Clin Immunol"},{"key":"1356_CR35","doi-asserted-by":"publisher","first-page":"48972","DOI":"10.18632\/oncotarget.16903","volume":"8","author":"JY Bae","year":"2017","unstructured":"Bae JY, Lee SW, Shin YH, Lee JH, Jahng JW, Park K. P2X7 receptor and NLRP3 inflammasome activation in head and neck cancer. Oncotarget. 2017;8:48972\u201382.","journal-title":"Oncotarget"},{"key":"1356_CR36","unstructured":"Wu C, Li K, Yu C, Hsieh S. Autoantibodies from Sj\u00f6gren\u2019s syndrome enhance NLRP3 inflammasome activation and il-18 production in human salivary gland cell line A-253 [abstract]. Arthritis Rheumatol. 2019;71(suppl 10)."},{"key":"1356_CR37","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.immuni.2015.06.003","volume":"42","author":"IS Afonina","year":"2015","unstructured":"Afonina IS, M\u00fcller C, Martin SJ, Beyaert R. Proteolytic Processing of Interleukin-1 Family Cytokines: Variations on a Common Theme. Immunity. 2015;42:991\u20131004.","journal-title":"Immunity"},{"key":"1356_CR38","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jdermsci.2010.05.004","volume":"59","author":"Y Omoto","year":"2010","unstructured":"Omoto Y, Yamanaka K, Tokime K, Kitano S, Kakeda M, Akeda T, et al. Granzyme B is a novel interleukin-18 converting enzyme. J Dermatol Sci. 2010;59:129\u201335.","journal-title":"J Dermatol Sci"},{"key":"1356_CR39","doi-asserted-by":"publisher","first-page":"6568","DOI":"10.4049\/jimmunol.167.11.6568","volume":"167","author":"S Sugawara","year":"2001","unstructured":"Sugawara S, Uehara A, Nochi T, Yamaguchi T, Ueda H, Sugiyama A, et al. Neutrophil proteinase 3-mediated induction of bioactive IL-18 secretion by human oral epithelial cells. J Immunol. 2001;167:6568\u201375.","journal-title":"J Immunol"},{"key":"1356_CR40","doi-asserted-by":"publisher","first-page":"5508","DOI":"10.4049\/jimmunol.1202121","volume":"189","author":"L Bossaller","year":"2012","unstructured":"Bossaller L, Chiang PI, Schmidt-Lauber C, Ganesan S, Kaiser WJ, Rathinam VAK, et al. Cutting Edge: FAS (CD95) Mediates Noncanonical IL-1\u03b2 and IL-18 Maturation via Caspase-8 in an RIP3-Independent Manner. J Immunol. 2012;189:5508\u201312.","journal-title":"J Immunol"},{"key":"1356_CR41","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.cell.2015.10.068","volume":"163","author":"C Wang","year":"2015","unstructured":"Wang C, Yosef N, Gaublomme J, Wu C, Lee Y, Clish CB, et al. CD5L\/AIM regulates lipid biosythesis and restrains Th17 cell pathogenicity. Cell. 2015;163:1413\u201327.","journal-title":"Cell"},{"key":"1356_CR42","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1084\/jem.20041257","volume":"201","author":"CL Langrish","year":"2005","unstructured":"Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, et al. IL-23 drives a pathogenic T-cell population that induces autoimmune inflammation. Journal Exp Med. 2005;201:233\u201340.","journal-title":"Journal Exp Med"},{"key":"1356_CR43","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1038\/mi.2015.13","volume":"8","author":"OJ Harrison","year":"2015","unstructured":"Harrison OJ, Srinivasan N, Pott J, Schiering C, Krausgruber T, Ilott NE, et al. Epithelial-derived IL-18 regulates Th17 cell differentiation and Foxp3+ Treg cell function in the intestine. Mucosal Immunol. 2015;8:1226\u201336.","journal-title":"Mucosal Immunol"},{"key":"1356_CR44","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/intimm\/12.2.151","volume":"12","author":"K Tominaga","year":"2000","unstructured":"Tominaga K, Yoshimoto T, Torigoe K, Kurimoto M, Matsui K, Hada T, et al. IL-12 synergizes with IL-18 or IL-1\u03b2 for IFN-\u03b3 production from human T cells. Int Immunol. 2000;12:151\u201360.","journal-title":"Int Immunol"},{"key":"1356_CR45","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/ni.2027","volume":"12","author":"L Codarri","year":"2011","unstructured":"Codarri L, Gy\u00fclv\u00e9szi G, Tosevski V, Hesske L, Fontana A, Magnenat L, et al. ROR\u03b3t drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat Immunol. 2011;12:560\u20137.","journal-title":"Nat Immunol"},{"key":"1356_CR46","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1084\/jem.20082584","volume":"206","author":"Y Yang","year":"2009","unstructured":"Yang Y, Weiner J, Liu Y, Smith AJ, Huss DJ, Winger R, et al. T-bet is essential for encephalitogenicity of both Th1 and Th17 cells. Journal Exp Med. 2009;206:1549\u201364.","journal-title":"Journal Exp Med"},{"key":"1356_CR47","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41418-022-01092-y","volume":"30","author":"R Nechanitzky","year":"2023","unstructured":"Nechanitzky R, Nechanitzky D, Ramachandran P, Duncan GS, Zheng C, G\u00f6bl C, et al. Cholinergic control of Th17 cell pathogenicity in experimental autoimmune encephalomyelitis. Cell Death Differ. 2023;30:407\u201316.","journal-title":"Cell Death Differ"},{"key":"1356_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00380-3","volume":"8","author":"TM Carr","year":"2017","unstructured":"Carr TM, Wheaton JD, Houtz GM, Ciofani M. JunB promotes Th17 cell identity and restrains alternative CD4+ T-cell programs during inflammation. Nat Commun. 2017;8:301.","journal-title":"Nat Commun"},{"key":"1356_CR49","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202100944R","volume":"35","author":"A Zafar","year":"2021","unstructured":"Zafar A, Ng HP, Kim GD, Chan ER, Mahabeleshwar GH. BHLHE40 promotes macrophage pro-inflammatory gene expression and functions. FASEB J. 2021;35:e21940.","journal-title":"FASEB J"},{"key":"1356_CR50","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1136\/gutjnl-2021-326070","volume":"72","author":"L Wang","year":"2023","unstructured":"Wang L, Liu Y, Dai Y, Tang X, Yin T, Wang C, et al. Single-cell RNA-seq analysis reveals BHLHE40-driven pro-tumor neutrophils with hyperactivated glycolysis in pancreatic tumor microenvironment. Gut. 2023;72:958\u201371.","journal-title":"Gut"},{"key":"1356_CR51","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1182\/blood.2019001696","volume":"135","author":"C Piper","year":"2020","unstructured":"Piper C, Zhou V, Komorowski R, Szabo A, Vincent B, Serody J, et al. Pathogenic Bhlhe40+ GM-CSF+ CD4+ T cells promote indirect alloantigen presentation in the GI tract during GVHD. Blood. 2020;135:568\u201381.","journal-title":"Blood"},{"key":"1356_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4551","volume":"5","author":"CC Lin","year":"2014","unstructured":"Lin CC, Bradstreet TR, Schwarzkopf EA, Sim J, Carrero JA, Chou C, et al. Bhlhe40 controls cytokine production by T cells and is essential for pathogenicity in autoimmune neuroinflammation. Nature Commun. 2014;5:3551.","journal-title":"Nature Commun"},{"key":"1356_CR53","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.semcancer.2022.03.025","volume":"86","author":"W Li","year":"2022","unstructured":"Li W, Deng X, Chen J. RNA-binding Proteins in Regulating mRNA Stability and Translation: Roles and Mechanisms in Cancer. Semin Cancer Biol. 2022;86:664\u201377.","journal-title":"Semin Cancer Biol"},{"key":"1356_CR54","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1084\/jem.20151289","volume":"213","author":"K Masuda","year":"2016","unstructured":"Masuda K, Ripley B, Nyati KK, Dubey PK, Zaman MMU, Hanieh H, et al. Arid5a regulates na\u00efve CD4+ T-cell fate through selective stabilization of Stat3 mRNA. J Exp Med. 2016;213:605\u201319.","journal-title":"J Exp Med"},{"key":"1356_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112065","volume":"133","author":"J Long","year":"2024","unstructured":"Long J, Zhao W, Xiang Y, Wang Y, Xiang W, Liu X, et al. STAT3 promotes cytoplasmic-nuclear translocation of RNA-binding protein HuR to inhibit IL-1\u03b2-induced IL-8 production. Int Immunopharmacol. 2024;133:112065.","journal-title":"Int Immunopharmacol"},{"key":"1356_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113033","volume":"42","author":"CD Fernando","year":"2023","unstructured":"Fernando CD, Jayasekara WSN, Inampudi C, Kohonen-Corish MRJ, Cooper WA, Beilharz TH, et al. A STAT3 protein complex required for mitochondrial mRNA stability and cancer. Cell Rep. 2023;42:113033.","journal-title":"Cell Rep."},{"key":"1356_CR57","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s11658-023-00521-1","volume":"29","author":"S Liu","year":"2024","unstructured":"Liu S, Li W, Liang L, Zhou Y, Li Y. The regulatory relationship between transcription factor STAT3 and noncoding RNA. Cell Mol Biol Lett. 2024;29:4.","journal-title":"Cell Mol Biol Lett"},{"key":"1356_CR58","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s13105-022-00924-2","volume":"79","author":"S Li","year":"2023","unstructured":"Li S, Ni Y, Li C, Xiang Q, Zhao Y, Xu H, et al. Long noncoding RNA SNHG1 alleviates high glucose-induced vascular smooth muscle cells calcification\/senescence by posttranscriptionally regulating Bhlhe40 and autophagy via Atg10. J Physiol Biochem. 2023;79:83\u2013105.","journal-title":"J Physiol Biochem"},{"key":"1356_CR59","first-page":"143","volume":"1","author":"A Haghikia","year":"2012","unstructured":"Haghikia A, Hoch M, Stapel B, Hilfiker-Kleiner D. STAT3 regulation of and by microRNAs in development and disease. JAKSTAT. 2012;1:143\u201350.","journal-title":"JAKSTAT"},{"key":"1356_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-43577-x","volume":"13","author":"W Qi","year":"2023","unstructured":"Qi W, Liu Q, Fu W, Shi J, Shi M, Duan S, et al. BHLHE40, a potential immune therapy target, regulated by FGD5-AS1\/miR-15a-5p in pancreatic cancer. Sci Rep. 2023;13:16400.","journal-title":"Sci Rep."},{"key":"1356_CR61","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.cell.2011.07.033","volume":"146","author":"EV Dang","year":"2011","unstructured":"Dang EV, Barbi J, Yang HY, Jinasena D, Yu H, Zheng Y, et al. Control of T(H)17\/T(reg) balance by hypoxia-inducible factor 1. Cell. 2011;146:772\u201384.","journal-title":"Cell"},{"key":"1356_CR62","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/nm.3704","volume":"20","author":"L Berod","year":"2014","unstructured":"Berod L, Friedrich C, Nandan A, Freitag J, Hagemann S, Harmrolfs K, et al. De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells. Nat Med. 2014;20:1327\u201333.","journal-title":"Nat Med"},{"key":"1356_CR63","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.4049\/jimmunol.2000060","volume":"204","author":"R Qiu","year":"2020","unstructured":"Qiu R, Yu X, Wang L, Han Z, Yao C, Cui Y, et al. Inhibition of Glycolysis in Pathogenic TH17 Cells through Targeting a miR-21\u2013Peli1\u2013c-Rel Pathway Prevents Autoimmunity. J Immunol. 2020;204:3160\u201370.","journal-title":"J Immunol"},{"key":"1356_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-022-01103-x","volume":"7","author":"F Xiao","year":"2022","unstructured":"Xiao F, Rui K, Han M, Zou L, Huang E, Tian J, et al. Artesunate suppresses Th17 response by inhibiting IRF4-mediated glycolysis and ameliorates Sjogren\u2019s syndrome. Sig Transduct Target Ther. 2022;7:1\u20133.","journal-title":"Sig Transduct Target Ther"},{"key":"1356_CR65","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.cmet.2022.02.015","volume":"34","author":"SM Hochrein","year":"2022","unstructured":"Hochrein SM, Wu H, Eckstein M, Arrigoni L, Herman JS, Schumacher F, et al. The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming. Cell Metab. 2022;34:516\u2013532.e11.","journal-title":"Cell Metab"},{"key":"1356_CR66","doi-asserted-by":"crossref","unstructured":"Liu J, Du D, Huang Y, Tian J, Wang X, Chen L, et al. CCDC86-BHLHE40-ATF3 axis promotes aerobic glycolysis and tumor development in glioma. Genes & Diseases 2025;101643.","DOI":"10.1016\/j.gendis.2025.101643"},{"key":"1356_CR67","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/art.39859","volume":"69","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, et al. 2016 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for Primary Sj\u00f6gren\u2019s Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts. Arthritis Rheumatol. 2017;69:35\u201345.","journal-title":"Arthritis Rheumatol"},{"key":"1356_CR68","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri M, Orbai AM, Alarc\u00f3n GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64:2677\u201386.","journal-title":"Arthritis Rheum"},{"key":"1356_CR69","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/01.ASN.0000108969.21691.5D","volume":"15","author":"JJ Weening","year":"2004","unstructured":"Weening JJ, D\u2019Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol. 2004;15:241\u201350.","journal-title":"J Am Soc Nephrol"},{"key":"1356_CR70","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/s41423-023-01049-2","volume":"20","author":"K Ma","year":"2023","unstructured":"Ma K, Du W, Wang S, Xiao F, Li J, Tian J, et al. B1-cell-produced anti-phosphatidylserine antibodies contribute to lupus nephritis development via TLR-mediated Syk activation. Cell Mol Immunol. 2023;20:881\u201394.","journal-title":"Cell Mol Immunol"},{"key":"1356_CR71","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2319856121","volume":"121","author":"CM Tilsed","year":"2024","unstructured":"Tilsed CM, Sadiq BA, Papp TE, Areesawangkit P, Kimura K, Noguera-Ortega E, et al. IL7 increases targeted lipid nanoparticle\u2013mediated mRNA expression in T cells in vitro and in vivo by enhancing T-cell protein translation. Proceedings Natl Acad Sci. 2024;121:e2319856121.","journal-title":"Proceedings Natl Acad Sci"},{"key":"1356_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s12896-024-00839-4","volume":"24","author":"N Alawar","year":"2024","unstructured":"Alawar N, Schirra C, Hohmann M, Becherer U. A solution for highly efficient electroporation of primary cytotoxic T lymphocytes. BMC Biotechnol. 2024;24:16.","journal-title":"BMC Biotechnol"},{"key":"1356_CR73","first-page":"E565","volume":"12","author":"GA Scardina","year":"2007","unstructured":"Scardina GA, Span\u00f3 G, Carini F, Spicola M, Valenza V, Messina P, et al. Diagnostic evaluation of serial sections of labial salivary gland biopsies in Sj\u00f6gren\u2019s syndrome. Med Oral Patol Oral Cir Bucal. 2007;12:E565\u2013568.","journal-title":"Med Oral Patol Oral Cir Bucal"}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-025-01356-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-025-01356-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-025-01356-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T23:01:33Z","timestamp":1764457293000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-025-01356-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":73,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1356"],"URL":"https:\/\/doi.org\/10.1038\/s41423-025-01356-w","relation":{},"ISSN":["2042-0226"],"issn-type":[{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"18 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests. LL is an editorial board member of Cellular & Molecular Immunology, but he has not been involved in the peer review or the decision-making of the article.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}